Evotec Launches the First Translational BRIDGE in Germany in Collaboration with Bristol-Myers
Evotec SE, a publicly listed drug discovery and development company headquartered in Hamburg, Germany, has launched beLAB2122, a translational $
Read moreEvotec SE, a publicly listed drug discovery and development company headquartered in Hamburg, Germany, has launched beLAB2122, a translational $
Read moreFrench pharma giant Sanofi is set to acquire Tidal Therapeutics for $470m, adding the biotech’s novel mRNA-based research platform with
Read moreThe unique 3DProSeed® ready-to-use 96-well microtiter plate developed by Ectica Technologies contains pre-assembled synthetic hydrogels, ready for screening 3D cell
Read moreThe cutting-edge multispectral tissue cytometry hardware TissueFAXS SPECTRA, developed by TissueGnostics, has the unique ability to enable multispectral imaging of
Read moreThe modern brightfield and fluorescence scanning system by TissueGnostics offers unparalleled flexibility for researchers working on tissue-based cell culture analysis
Read moreTissueGnostics has launched a new cutting-edge compact digital brightfield slide scanner with remote real-time viewing and live stitching modes combined
Read moreRoche has revealed that their assay Elecsys® GDF-15 assay has been approved as a companion diagnostic (CDx) in cancer therapy
Read moreThe next-gen TissueFAXS Q confocal imaging systems are highly flexible scanning platforms which offer the advantages of both laser-free ultra-fast
Read moreThe StrataQuest AI-assisted high-content screening (HCS) image cytometry software offers solutions for multiple applications in analysing large volumes of complex
Read moreThe cutting-edge TissueFAXS PLUS high-content screening system by TissueGnostics is engineered for advanced multi-channel fluorescence microscopy and exceptional high-resolution imaging
Read more